NCT05551663

Brief Summary

Heart failure with a preserved ejection fraction (HFpEF) is a major cause of morbidity and mortality. Hypertension remains one of the major modifiable risk factors in HFpEF development and progression. The role of aerobic exercise training for blood pressure (BP) reduction is well established, with positive cardiac, vascular, and neurohumoral adaptations all cited as potential mechanisms for improving arterial haemodynamics. However, recent evidence has shown that a specific type of resistance exercise alone, known as isometric exercise (IE), produces greater mean BP reductions than what has traditionally been seen with both aerobic and dynamic resistance exercise training programmes. Indeed, short duration IE training causes significant improvements in both cardiac structure and function, in addition to inducing significant reductions in resting BP in normotensive, pre-hypertensive and hypertensive individuals. This study aims to compare the acute and chronic effects of an IE training intervention on diastolic function parameters in patients who have been diagnosed with HFpEF compared to a control group.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 1, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

September 23, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

October 26, 2022

Status Verified

October 1, 2022

Enrollment Period

10 months

First QC Date

September 1, 2022

Last Update Submit

October 25, 2022

Conditions

Keywords

Heart FailureIsometric Exercise Training

Outcome Measures

Primary Outcomes (1)

  • Diastolic function

    Whether an isometric exercise training (IET) programme statistically significantly improves diastolic function parameters in patients who have been diagnosed with HFpEF. These parameters will be measured quantitatively using transthoracic echocardiography and using measures of transmitral filling velocity (early \[E\] and late \[A\] left ventricular filling velocities), the E/A ratio and tissue Doppler velocities (mitral annulus velocities in diastole \[E'\]) and the E/E' ratio.

    1-year

Secondary Outcomes (1)

  • Blood pressure

    1-year

Study Arms (2)

Isometric exercise training

EXPERIMENTAL
Other: Isometric exercise training

Control group

NO INTERVENTION

Interventions

Participants randomised to the intervention will perform a 4-week programme of isometric exercise training.

Isometric exercise training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with HFpEF.
  • Patients under the care of a St George's Heart Failure cardiology consultant.
  • Patients willing and able to provide informed consent.
  • Male and female, aged 18 years or above.
  • Medically optimised patients.

You may not qualify if:

  • Recent myocardial infarction or electrocardiographic changes, complete heart block, unstable angina.
  • Inability or unwilling to provide informed consent.
  • Male and female, aged 17 years or younger.
  • Patients with HFrEF.
  • Patients with musculoskeletal injury that could conceivably be affected by their involvement.
  • Resting BP values of ≥180/110 mmHg.
  • Patients unable to understand verbal and written English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2022

First Posted

September 23, 2022

Study Start

November 1, 2022

Primary Completion

September 1, 2023

Study Completion

December 1, 2023

Last Updated

October 26, 2022

Record last verified: 2022-10